Editorial: progress towards more comprehensively understanding the sources of corticosteroids for patients with IBD
- PMID: 35934853
- DOI: 10.1111/apt.17137
Editorial: progress towards more comprehensively understanding the sources of corticosteroids for patients with IBD
Comment in
-
Editorial: progress towards more comprehensively understanding the sources of corticosteroids for patients with inflammatory bowel disease-authors' reply.Aliment Pharmacol Ther. 2022 Sep;56(5):898-899. doi: 10.1111/apt.17140. Aliment Pharmacol Ther. 2022. PMID: 35934863 No abstract available.
Comment on
-
Sources of excess steroid prescriptions and clinical adverse outcomes associated with steroid excess in patients with inflammatory bowel disease: The Leeds IBD Steroids study.Aliment Pharmacol Ther. 2022 Aug;56(3):501-509. doi: 10.1111/apt.17039. Epub 2022 May 24. Aliment Pharmacol Ther. 2022. PMID: 35611471
References
REFERENCES
-
- Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68(Suppl 3):s1-s106.
-
- Torres J, Bonovas S, Doherty G, Kucharzik T, Gisbert JP, Raine T, et al. ECCO guidelines on therapeutics in Crohn's disease: medical treatment. J Crohns Colitis. 2019;14(1):4-22.
-
- Raine T, Bonovas S, Burisch J, Kucharzik T, Adamina M, Annese V, et al. ECCO guidelines on therapeutics in ulcerative colitis: medical treatment. J Crohns Colitis. 2021;16(1):2-17.
-
- Feuerstein JD, Ho EY, Shmidt E, Singh H, Falck-Ytter Y, Sultan S, et al. AGA clinical practice guidelines on the medical management of moderate to severe luminal and perianal fistulizing Crohn's disease. Gastroenterol. 2021;160(7):2496-508.
-
- Feuerstein JD, Isaacs KL, Schneider Y, Siddique SM, Falck-Ytter Y, Singh S, et al. AGA clinical practice guidelines on the management of moderate to severe ulcerative colitis. Gastroenterol. 2020;158(5):1450-61.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical